CEFALY Technology, maker of the #1 neuromodulation treatment for migraine, announced it has selected PayrHealth, the industry’s leading Complete Payor Management solution, to manage payor contracting on behalf of the company.
By leveraging PayrHealth’s extensive expertise, CEFALY aims to reduce out-of-pocket costs and improve access to its FDA-cleared medical device, allowing patients nationwide to receive effective, non-invasive migraine relief through their insurance coverage.
PayrHealth brings extensive experience negotiating with payors on behalf of a wide variety of healthcare providers, ensuring that cutting-edge treatments like CEFALY receive fair reimbursement and broad coverage.
Health Technology Insights: VSee Health Wins $444K Contract, Expanding in Public Sector Healthcare
“In multiple clinical trials, CEFALY’s neuromodulation device has been proven to help patients reduce the frequency of migraine attacks and relieve debilitating symptoms without medication,” said Jen Trainor-McDermott, CEO of CEFALY Technology. “Contracting with payors is crucial to giving patients the opportunity to treat migraine pain without the side effects and expense of pharmaceuticals. I’m optimistic that our work with PayrHealth will enable more migraine patients to access a life-changing treatment.”
Migraine is a complex and often debilitating neurological disorder that affects more than 37 million Americans and more than 1 billion people worldwide. Despite migraine’s prevalence, the condition is often misunderstood, underdiagnosed, and ineffectively treated.
CEFALY’s breakthrough neuromodulation device uses tiny electrical impulses to stimulate and desensitize the trigeminal nerve, relieving migraine pain and reducing the frequency of attacks. CEFALY is fully covered by VA healthcare benefits for veterans and is an eligible medical expense for HSA/FSA plans. However, insurance companies are just beginning to recognize CEFALY as a clinically proven and neurologist-recommended treatment.
Health Technology Insights: Colorado Cancer Center and Flatiron Health Partner to Improve Clinical Trials
CEFALY is committed to making migraine treatment more accessible. Navigating insurance requirements can be complex, so CEFALY has created the CEFALY Patient Guide to Insurance Reimbursement to help patients understand how to submit a claim for potential coverage.
It’s important for patients to know that CEFALY does not have any current contracts with commercial payors, Medicaid, or Medicare. By partnering with the experts at PayrHealth, CEFALY hopes to establish those contracts for the benefit of patients.
CEFALY offers a 90-day money back guarantee, so that patients can return the device if they’re not able to get insurance reimbursement, or if they don’t see the results they want. CEFALY also offers flexible payment plans through PayPal Credit and Affirm.
“Migraine pain should never stop anyone from living the life they want,” said Trainor-McDermott. “We’ll never stop fighting for migraine patients to get access to the drug-free treatment they deserve.”
Health Technology Insights: Arieli and Shaare Zedek Launch SHAAR, a New Innovation Hub in Jerusalem
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – prnewswire
